Home/Filings/4/0001140361-10-037503
4//SEC Filing

MCGRANE MICHAEL 4

Accession 0001140361-10-037503

CIK 0000821995other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 3:07 PM ET

Size

11.0 KB

Accession

0001140361-10-037503

Insider Transaction Report

Form 4
Period: 2010-09-15
MCGRANE MICHAEL
Senior VP & General Counsel
Transactions
  • Award

    Employee stock option (right to buy)

    2010-09-15$1.07/sh+150,000$160,500150,000 total
    Exercise: $1.07From: 2011-03-11Exp: 2017-09-15$0.01 par value common stock (150,000 underlying)
Footnotes (1)
  • [F1]25% of the grant vests on March 1, 2011, and each of the following three anniversaries of that date, provided, however, that 50% of unvested options will vest upon the acceptance by the US Food and Drug Administration of the Company's new drug application for the prevention of preterm birth.

Issuer

COLUMBIA LABORATORIES INC

CIK 0000821995

Entity typeother

Related Parties

1
  • filerCIK 0001240145

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 3:07 PM ET
Size
11.0 KB